Search results
Nuvo Enhances Credit Application Software with Equifax Commercial Credit Information
KLAS Las Vegas· 8 hours agoNuvo, the fastest trade credit management platform for B2B sellers, has announced a strategic relationship with Equifax®, a leading global data, analytics ...
Analyst Report: Equifax, Inc.
Argus Research via Yahoo Finance· 12 hours agoEquifax is a global provider of information and credit reporting solutions for businesses, governments and ...
Equifax cuts stock target, maintains buy amid mortgage headwinds By Investing.com
Investing.com· 8 hours agoOn Wednesday, Citi adjusted its outlook for Equifax Inc . Despite the reduction, Citi has kept a Buy...
What to do when your credit card application is denied
Yahoo Personal Finance· 7 hours agoBut if your credit card application was denied because of information on your credit report, view...
Lindbrook Capital LLC Increases Position in Equifax Inc. (NYSE:EFX)
ETF DAILY NEWS· 22 hours agoEquifax Inc. (NYSE:EFX – Free Report) by 25.5% during the fourth quarter, according to the company...
Decoding Equifax Inc (EFX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoEquifax must continually innovate and differentiate its offerings to maintain its competitive edge. Additionally, the rise of fintech startups ...
Equifax Inc. to Post Q2 2024 Earnings of $1.72 Per Share, William Blair Forecasts (NYSE:EFX)
ETF DAILY NEWS· 1 day ago:EFX – Free Report) – Research analysts at William Blair reduced their Q2 2024 earnings per share...
No-credit-check loans: What are they and how do they work?
Bankrate via AOL· 5 hours agoYou repay the loan plus interest just like any other loan. Unlike a loan that requires a credit...
Sumitomo Mitsui DS Asset Management Company Ltd Grows Position in Equifax Inc. (NYSE:EFX)
ETF DAILY NEWS· 20 hours ago(NYSE:EFX – Free Report) by 2.2% in the fourth quarter, according to the company in its most recent...
Equifax (NYSE:EFX) PT Lowered to $272.00
ETF DAILY NEWS· 2 days agoEquifax (NYSE:EFX – Free Report) had its target price cut by Oppenheimer from $291.00 to $272.00 in a research note published on Friday, Benzinga
